What does the evidence say about Beta-Hydroxy-Beta-Methylbutyrate Muscle Recovery Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Beta-Hydroxy-Beta-Methylbutyrate Muscle Recovery Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Objectives Medical nutrition therapy significantly impacts cardiovascular risk and overall health, but effects on muscle diseases remain unclear. [Talreja T (2026); evidence level 1] - In inflammatory myopathies, creatine (loading dose 20 g/day, maintenance 3 g/day) combined with exercise improved high-intensity functional performance in PM and DM over 6 months. [Talreja T (2026); evidence level 1] - In Duchenne muscular dystrophy, creatine (2-10 g/day for 8-16 weeks) improved maximal voluntary contraction and fatigue resistance. [Talreja T (2026); evidence level 1] - This systematic review evaluates the safety and efficacy of dietary interventions and supplements on muscle disease outcomes. [Talreja T (2026); evidence level 1] - Conclusion Acute post-exercise HMB-FA supplementation in elite judo athletes did not significantly influence muscle damage or oxidative stress markers but transiently increased antioxidant enzyme activities (CAT, GPX, and SOD). [Tayebi SM (2026); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.